Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease

Background: Left atrial (LA) function is an important determinant of left ventricular (LV) filling, playing a key role in maintaining optimal cardiac performance. Pimobendan is a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects. The present study sought to investigate...

Full description

Bibliographic Details
Main Authors:	Fabio Sarcinella, Joao Neves, Thomas W. Maddox, Hannah M. Hodgkiss-Geere, Elizabeth F. Bode, Joanna Dukes-McEwan
Format:	Article
Language:	English
Published:	Tripoli University 2019-12-01
Series:	Open Veterinary Journal
Subjects:	atrioventricular valve degeneration canine chronic valvular disease phosphodiesterase inhibitor vetmedin
Online Access:	https://www.openveterinaryjournal.com/OVJ-2019-08-267%20F.%20sarcinella%20et%20al.pdf

Similar Items

Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study
by: Maureen S. Oldach, et al.
Published: (2019-02-01)

Role of the Epicardium in the Development of the Atrioventricular Valves and Its Relevance to the Pathogenesis of Myxomatous Valve Disease
by: Renélyn Wolters, et al.
Published: (2021-05-01)

Evaluation of right ventricular function using conventional and real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease
by: Aherne, Michael
Published: (2017)

Mitral valve repair. Quadrangular resection of the posterior leaflet in patients with myxomatous degeneration
by: Pablo Maria Alberto Pomerantzeff, et al.
Published: (1999-09-01)

Advanced Echocardiographic Imaging In Dogs With Myxomatous Mitral Valve Disease
by: Menciotti, Giulio
Published: (2017)

Effectiveness of sildenafil in pulmonary hypertension secondary to mitral valve disease
by: Tinni Mitra, et al.
Published: (2020-01-01)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
by: Carlotta Valente, et al.
Published: (2021-09-01)

Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
by: Adrian Boswood, et al.
Published: (2020-05-01)

Asymptomatic Myxomatous Degeneration of the Mitral Valve, in a Young Male
by: Opris Carmen, et al.
Published: (2020-12-01)

The pathomechanism of human myxomatous valvular degeneration at the mechanical and cellular level
by: Chang Hu, et al.
Published: (2021-06-01)

Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease
by: Megan H. Poad, et al.
Published: (2020-09-01)

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
by: Bruce W. Keene, et al.
Published: (2019-05-01)

Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease
by: Marco Baron Toaldo, et al.
Published: (2020-09-01)

The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
by: Katja Höglund, et al.
Published: (2020-08-01)

Reproducibility of echocardiographic indices of left atrial size in dogs with subclinical myxomatous mitral valve disease
by: Weihow Hsue, et al.
Published: (2020-09-01)

Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human
by: Greg R. Markby, et al.
Published: (2017-07-01)

Mitral Valve Prolapse
by: Marc Gewillig, et al.
Published: (2017-04-01)

Mitral valve repair [version 1; referees: 3 approved]
by: Alberto Pozzoli, et al.
Published: (2016-06-01)

WAS THE CLASSIFICATION ABLE TO DIVIDE DOGS WITH MYXOMATOUS MITRAL VALVE DISEASE ACCORDING TO THE SEVERITY OF THE DISEASE?
by: A. Pankov
Published: (2020-03-01)

Echocardiographic Investigation of Canine Myxomatous Mitral Valvular Disease
by: Wesselowski, Sonya Rae
Published: (2014)

Morphometry of mitral valve
by: Parmatma P Mishra, et al.
Published: (2014-01-01)

Study of mitral valve in human cadaveric hearts
by: S A Gunnal, et al.
Published: (2012-01-01)

Red Cell Distribution Width Has a Negative Prognostic Role in Dogs with Myxomatous Mitral Valve Disease
by: Carlo Guglielmini, et al.
Published: (2021-03-01)

Magnesium in Idiopathic Mitral Valve Prolapse
by: Bilovol Oleksandr, et al.
Published: (2021-06-01)

Myxomatous degeneration of the mitral valve
by: Felippe Lazar Neto, et al.
Published: (2019-10-01)

Unusual Presentation of Aortic Valve Infective Endocarditis in a Dog: Aorto-Cavitary Fistula, Tricuspid Valve Endocarditis, and Third-Degree Atrioventricular Block
by: Giovanni Romito, et al.
Published: (2021-03-01)

Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve
by: Jaime Ibarrola, et al.
Published: (2020-07-01)

Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease
by: Natalia Druzhaeva, et al.
Published: (2021-09-01)

Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study
by: Marcos Gradim Tiveron, et al.
Published: (2017-04-01)

Case report: early aortic valve degeneration associated with interstitial deletion of chromosome 2–46,XX,del (2)(q31.3; q32.2)
by: Raymond Pfister, et al.
Published: (2020-04-01)

Effects of Pimobendan and Enalapril for Mitral Valve Disease in Dogs
by: Yuan- Jen Mai, et al.
Published: (2009)

To repair or not to repair: a case report of atrioventricular groove hematoma during mitral valve surgery
by: Hiroshi Nagamine, et al.
Published: (2019-01-01)

Mitral annulus dynamics in myxomatous mitral valve disease
by: Maria-Magdalena Gurzun, et al.
Published: (2021-03-01)

Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling
by: Greg R. Markby, et al.
Published: (2020-04-01)

Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly.
by: Nayeli Iwanuk, et al.
Published: (2019-01-01)

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study
by: Stephanie Klein, et al.
Published: (2021-09-01)

Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve disease.
by: Qinghong Li, et al.
Published: (2020-01-01)

Floppy Mitral Valve (FMV) – Mitral Valve Prolapse (MVP) – Mitral Valvular Regurgitation and FMV/MVP Syndrome
by: Konstantinos Dean Boudoulas, MD, et al.
Published: (2016-03-01)

Plástica mitral Mitral repair
by: Domingo M Braile, et al.
Published: (1990-08-01)

Myxomatous mitral valve disease in dogs - an update and perspectives
by: Aleksandra Domanjko Petrič
Published: (2015-03-01)